Medical Products
Customer & Market Due Diligence Of Neuroscience Research Lab Instrument Manufacturer: Establishing Growth Outlook And Competitive Positioning
Conducted customer & market due diligence to establish target’s growth outlook and line expansion/acquisition opportunities. To this end, Gotham: established neuroscience research growth outlook; conducted interviews with academic and non-profit research laboratories; built robust view of products and competition via a bottom-up effort; built a market sizing model based on ~100K NIH grants; and developed a software monetization strategy. Gotham’s robust and fact-based assessment provided our client confidence in moving forward with the acquisition.
Show Details
Delivery Performance Turnaround at Precision Medical Device Component Manufacturer: Rapid Backlog Reduction and Sustainable Delivery System
Rapidly reduced backlog and created a robust delivery system. Backlog reduction effort included rolling out prioritized schedule, developing and implementing debottlenecking strategies, creating a cross-functional team resolving issues that were stopping scheduled jobs. Robust delivery system initiatives included: 1) turning on the planning and scheduling functionality of the ERP/cleaning up system data and parameters, developing SOPs for data entry, training the workforce on the SOP; 2) improving the accuracy of time estimates by revamping engineering process; and 3) reducing quality defects by 20%. Within 3 months, on-time performance improved from 59% to 93% while lead time shrunk from 13-16 weeks to 10 weeks, with backlog reduced in half.
Show Details
Customer & Market Due Diligence Of Clinical Trial Packaging Manufacturer: Establishing Growth Outlook And Competitive Positioning
Conducted a 3-week customer & market due diligence to: establish market size/growth outlook; understand insourcing risks and substitution threats; and establish the target's reputation/competitive positioning. To this end, Gotham: conducted 26 interviews with clinical trial sponsors (pharmaceutical and biotech companies), CRO, CMO, and CPO companies; assessed substitution threats; identified and profiled key clinical trial packaging competitors; established clinical trial growth outlook in light of COVID-19; and built a bottom-up market sizing model based on individual clinical trial level details. Our client was able to move forward on its bid with confidence and successfully closed the transaction.
Show Details
Operational Due Diligence of Medical Products Ecommerce Retailer: Deciphering and Controlling Outsourced Distribution Cost Structures
Modeled the warehouse, outbound freight, inventory, and inbound freight cost structures of a 3rd-party logistics company in the midst of contract renegotiations and a move to a new warehouse. Identified $1.3MM in financial exposure and weaknesses in contracted outbound freight pricing which drove operational instability, resulting in a 22% reduction in the acquisition price.
Show Details
Proactive Investment Strategy for New Private Equity Fund: Identifying Promising Niche Industries to Create an Investment Framework for Inclusion in the PPM
Worked with this mid-market PE firm to translate the broad investment criteria for the new fund into specific quantitative and qualitative criteria targeting promising industries. Conducted analytical research to identify 7 focus industries, and assessed trends/dynamics and developed benchmarks for each of the industries to be used in deal evaluation. PE firm successfully raised the new fund and closed 3 deals within 2 years in the targeted industry niches.
Show Details
Marketing Effectiveness for Multi-Billion-Dollar Drug Product: Understanding and Analyzing the Impact of Generic Entry and Developing Financial and Manufacturing Plan to Optimize Marketing Spend
Assessed generic competitive landscape for $2B drug, including profiling costs and lead time for generic market entry, generating likely penetration scenarios (pricing and market share), and quantifying financial impact of generic launch sequences across 7 major worldwide markets. The study resulted in creation of a re-usable proactive planning tool for modeling the effects of generic product entry into the market.
Show Details